Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHudson Capital Management LLC
Latest Disclosed Ownership52,827 shares
Latest Disclosed Value $ 7,362,520
Hudson Capital Management LLC reports 1.52% increase in ownership of GILD / Gilead Sciences, Inc.

On April 13, 2026 - Hudson Capital Management LLC filed a 13F-HR form disclosing ownership of 52,827 shares of Gilead Sciences, Inc. (CH:GILD) valued at $7,362,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 52,036 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 52,827 791 1.52 7,363 15.28 1.9027
2026-01-21 2025-12-31 13F GILEAD SCIENCES COM 375558103 52,036 -873 -1.65 6,387 8.75 1.6027
2025-10-21 2025-09-30 13F GILEAD SCIENCES COM 375558103 52,909 -644 -1.20 5,873 -1.09 1.5591
2025-07-28 2025-06-30 13F GILEAD SCIENCES COM 375558103 53,553 -239 -0.44 5,937 -1.49 1.6842
2025-04-11 2025-03-31 13F GILEAD SCIENCES COM 375558103 53,792 -2,310 -4.12 6,027 16.31 1.8370
2025-01-17 2024-12-31 13F GILEAD SCIENCES COM 375558103 56,102 -2,576 -4.39 5,182 5.35 1.6104
2024-10-09 2024-09-30 13F GILEAD SCIENCES COM 375558103 58,678 583 1.00 4,920 23.44 1.5681
2024-07-16 2024-06-30 13F GILEAD SCIENCES COM 375558103 58,095 9,178 18.76 3,986 11.22 1.3387
2024-04-19 2024-03-31 13F GILEAD SCIENCES COM 375558103 48,917 2,619 5.66 3,583 -4.45 1.2354
2024-01-11 2023-12-31 13F GILEAD SCIENCES COM 375558103 46,298 1,401 3.12 3,751 11.47 1.3595
2023-10-27 2023-09-30 13F GILEAD SCIENCES COM 375558103 44,897 2,018 4.71 3,365 1.82 1.3408
2023-07-13 2023-06-30 13F GILEAD SCIENCES COM 375558103 42,879 1,694 4.11 3,305 -3.31 1.2704
2023-04-18 2023-03-31 13F GILEAD SCIENCES COM 375558103 41,185 2,007 5.12 3,417 1.61 1.3565
2023-01-18 2022-12-31 13F GILEAD SCIENCES COM 375558103 39,178 800 2.08 3,363 42.02 1.3312
2022-10-12 2022-09-30 13F GILEAD SCIENCES COM 375558103 38,378 2,700 7.57 2,368 7.39 1.1792
2022-07-13 2022-06-30 13F GILEAD SCIENCES COM 375558103 35,678 5,065 16.55 2,205 21.15 1.0479
2022-04-25 2022-03-31 13F GILEAD SCIENCES COM 375558103 30,613 2,005 7.01 1,820 -12.37 0.7210
2022-01-19 2021-12-31 13F GILEAD SCIENCES COM 375558103 28,608 422 1.50 2,077 5.49 0.7524
2021-10-21 2021-09-30 13F GILEAD SCIENCES COM 375558103 28,186 580 2.10 1,969 3.58 0.7880
2021-07-22 2021-06-30 13F GILEAD SCIENCES COM 375558103 27,606 439 1.62 1,901 8.26 0.7873
2021-04-13 2021-03-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 27,167 555 2.09 1,756 13.29 0.7518
2021-01-20 2020-12-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 26,612 -1,227 -4.41 1,550 -11.88 0.6869
2020-10-16 2020-09-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 27,839 1,373 5.19 1,759 -13.61 0.8595
2020-07-21 2020-06-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 26,466 -1,901 -6.70 2,036 -4.01 1.0823
2020-04-15 2020-03-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 28,367 -331 -1.15 2,121 13.73 1.4070
2020-01-09 2019-12-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 28,698 1,382 5.06 1,865 7.74 0.9443
2019-10-22 2019-09-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 27,316 2,524 10.18 1,731 3.41 0.9638
2019-07-12 2019-06-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 24,792 3,674 17.40 1,675 22.01 0.9432
2019-05-09 2019-03-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 21,118 2,125 11.19 1,373 15.49 0.8365
2019-01-16 2018-12-31 13F GILEAD SCIENCES COM 375558103 18,993 895 4.95 1,188 -14.96 0.8659
2018-10-10 2018-09-30 13F GILEAD SCIENCES COM 375558103 18,098 337 1.90 1,397 11.05 1.0645
2018-07-11 2018-06-30 13F GILEAD SCIENCES COM 375558103 17,761 1,615 10.00 1,258 3.37 0.8757
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 16,146 1,939 13.65 1,217 19.55 0.8957
2018-01-23 2017-12-31 13F GILEAD SCIENCES COM 375558103 14,207 14,207 1,018 0.7469
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.